Japanese drugmaker Takeda has suffered a blow to its late-stage pipeline, after the FDA rejected its marketing application for TAK-721, a drug candidate that is trying to be the first approved therapy ...

Get the detailed quarterly/annual income statement for Takeda Pharmaceutical Company Limited (TAK). Find out the revenue, expenses and profit or loss over the last fiscal year.

Review the current Takeda Pharmaceutical Co Ltd ADR (TAK:XNYS) dividend yield and history to decide if TAK is the best investment for you.

Ah, Port. As warming as a cashmere jumper. The perfect way to end a supper, paired with cheese. A Christmas staple. It’s also a drink that carries with it a number of rules – age-old traditions that ...